Sort:
Date
Filter:
All

225 result(s) found

PepsiCo to buy tortilla chip maker Siete Foods for $1.2 billion https://www.cnbc.com/2024/10/01/pepsico-to-buy-siete-foods.html Oct 01, 2024 - Siete designs its tortilla chips and other products to meet dietary restrictions.
CVS Health strategic review brings segments into focus https://seekingalpha.com/news/4155128-cvs-health-segments-focus-amid-strategic-review?source=feed_sector_healthcare Oct 01, 2024 - CVS Health (CVS) business segment earns attention as multiple reports indicated on Monday that the healthcare conglomerate is weighing strategic options. Read more here.
CVS conducting strategic review, considering breakup https://www.boston.com/news/business/2024/10/01/cvs-conducting-strategic-review-considering-breakup/ Oct 01, 2024 -

CVS has been grappling with falling profit margins at its retail pharmacies and rising costs of patient care from Aetna, which generates about a third of its revenue.

The post CVS conducting strategic review, considering breakup appeared first on Boston.com.

Wall Street Breakfast Podcast: T-Mobile Settles Data Breach Cases With FCC For $31.5M https://seekingalpha.com/article/4724409-wall-street-breakfast-podcast-t-mobile-settles-data-breach-cases-with-fcc-for-31-5m?source=feed_tag_wall_st_breakfast Oct 01, 2024 - T-Mobile US to settle data breach cases with the FCC. CVS Health board considering company breakup as part of strategic review - reports. PepsiCo is reportedly on the hunt to acquire Siete.
CVS Health board considering company breakup as part of strategic review - reports https://seekingalpha.com/news/4154802-cvs-health-board-considering-company-breakup-part-strategic-review?source=feed_sector_healthcare Sep 30, 2024 - CVS Health's board is considering options amid activist pressure, including breaking up the company. Read more here.
'Stop ripping us off': Senate grills Novo Nordisk CEO on weight loss drug pricing https://www.cnbc.com/2024/09/24/novo-nordisk-ceo-to-testify-at-senate-over-weight-loss-drug-prices.html Sep 24, 2024 - Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown? https://www.fool.com/investing/2024/09/24/are-cvs-health-cigna-and-unitedhealth-group-bad-ne/?source=iedfolrf0000001 Sep 24, 2024 - The FTC is going after these PBMs. Is this an opportunity for investors?
Is CVS Health Stock a Buy? https://www.fool.com/investing/2024/09/22/is-cvs-health-stock-a-buy/?source=iedfolrf0000001 Sep 22, 2024 - It's been a year to forget for the healthcare company.
FTC sues drug middlemen for allegedly inflating insulin prices https://www.cnbc.com/2024/09/20/ftc-sues-drug-middlemen-for-allegedly-inflating-insulin-prices.html Sep 21, 2024 - The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.
UnitedHealth, Cigna, CVS PBMs targeted by FTC over inflated insulin prices https://seekingalpha.com/news/4151680-unitedhealth-cigna-cvs-pbms-targeted-ftc-inflated-insulin-prices?source=feed_sector_healthcare Sep 20, 2024 - FTC accuses top PBMs of inflating insulin prices, harming patients. Read more here.

Pages: 1234567891011...23

<<<Page 6>